Association of MDR1, CYP3A4*18B, and CYP3A5*3 polymorphisms with cyclosporine pharmacokinetics in Chinese renal transplant recipients

被引:0
|
作者
Xiao-yan Qiu
Zheng Jiao
Ming Zhang
Long-jin Zhong
Hui-qi Liang
Chun-lai Ma
Liang Zhang
Ming-kang Zhong
机构
[1] Fudan University,Clinical Pharmacy Laboratory, Huashan Hospital
[2] Fudan University,School of Pharmacy
[3] Fudan University,Department of Nephrology, Huashan Hospital
来源
European Journal of Clinical Pharmacology | 2008年 / 64卷
关键词
MDR1; CYP3A4*18B; CYP3A5*3; Cyclosporine; Renal transplantation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Impact of CYP3A5 and CYP3A4 gene polymorphisms on dose requirement of calcineurin inhibitors, cyclosporine and tacrolimus, in renal allograft recipients of North India
    Singh, Ranjana
    Srivastava, Aneesh
    Kapoor, Rakesh
    Sharma, Raj K.
    Mittal, Rama D.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 380 (02) : 169 - 177
  • [42] Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients
    Chowbay, B
    Cumaraswamy, S
    Cheung, YB
    Zhou, QY
    Lee, EJD
    PHARMACOGENETICS, 2003, 13 (02): : 89 - 95
  • [43] Association of CYP3A polymorphisms with the pharmacokinetics of cyclosporine A in early post-renal transplant recipients in China
    Meng, Xiang-guang
    Guo, Cheng-xian
    Feng, Guo-qing
    Zhao, Ying-chun
    Zhou, Bo-ting
    Han, Jian-le
    Chen, Xin
    Shi, Yong
    Shi, Hong-yao
    Yin, Ji-ye
    Peng, Xiang-dong
    Pei, Qi
    Zhang, Wei
    Wang, Guo
    He, Meng
    Liu, Min
    Yang, Jing-ke
    Zhou, Hong-hao
    ACTA PHARMACOLOGICA SINICA, 2012, 33 (12) : 1563 - 1570
  • [44] Single Nucleotide Polymorphisms of CYP3A4 and CYP3A5 in Romanian Kidney Transplant Recipients: Effect on Tacrolimus Pharmacokinetics in a Single-Center Experience
    Rotarescu, Corina Andreea
    Maruntelu, Ion
    Rotarescu, Ion
    Constantinescu, Alexandra-Elena
    Constantinescu, Ileana
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (07)
  • [45] Impact of CYP3A5 and CYP3A4 gene polymorphisms on dose requirement of calcineurin inhibitors, cyclosporine and tacrolimus, in renal allograft recipients of North India
    Ranjana Singh
    Aneesh Srivastava
    Rakesh Kapoor
    Raj K. Sharma
    Rama D. Mittal
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2009, 380 : 169 - 177
  • [46] Description of CYP3A4*22 and CYP3A5*3 frequencies and impact on first tacrolimus (TAC) doses in renal transplant recipients
    Lori, L.
    Zaidan, M.
    Furlan, V.
    Bouligand, J.
    Becquemont, L.
    Verstuyft, C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 : 159 - 160
  • [47] Influence of the CYP3A5 and MDR1 genetic polymorphisms on the pharmacokinetics of tacrolimus in healthy Korean subjects
    Choi, Ji H.
    Lee, Yoon J.
    Jang, Seong B.
    Lee, Jong-Eun
    Kim, Kyung H.
    Park, Kyungsoo
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 64 (02) : 185 - 191
  • [48] CYP3A5 and ABCB1 genotype influence tacrolimus and sirolimus pharmacokinetics in renal transplant recipients
    Li, Yi
    Yan, Lin
    Shi, Yunying
    Bai, Yangjuan
    Tang, Jiangtao
    Wang, Lanlan
    SPRINGERPLUS, 2015, 4
  • [49] Effect of Age and Allele Variants of CYP3A5, CYP3A4, and POR Genes on the Pharmacokinetics of Cyclosporin A in Pediatric Renal Transplant Recipients From Serbia
    Cvetkovic, Mirjana
    Zivkovic, Maja
    Bundalo, Maja
    Gojkovic, Ivana
    Spasojevic-Dimitrijeva, Brankica
    Stankovic, Aleksandra
    Kostic, Mirjana
    THERAPEUTIC DRUG MONITORING, 2017, 39 (06) : 589 - 595
  • [50] Influence of CYP3A5 genetic polymorphism on cyclosporine A metabolism and elimination in Chinese renal transplant recipients
    Chu, Xiao-man
    Hao, Hai-ping
    Wang, Guang-ji
    Guo, Lian-qing
    Min, Pei-qing
    ACTA PHARMACOLOGICA SINICA, 2006, 27 (11) : 1504 - 1508